Vivelle-Dot, the #1 prescribed transdermal estrogen therapy, is FDA approved for 4 indications.
Delivery Optimized Thermodynamics (DOT) Matrix® Technology provides multiple benefits.
Extensive patient support in and out of the office.
The information contained within this Web site is appropriate for U.S. healthcare professionals only. A visit to this site should not replace a visit to your doctor. Copyright © 2011 Novogyne Pharmaceuticals. All rights reserved5/11 VVD-1051503
Share information about Vivelle-Dot® by e-mailing this Web site to a colleague.